Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase I/II study of FibroCell-001 for lumbar intervertebral disc degeneration
CTR20254252Phase 2Active
- Sponsor
- Zhuiyuan Medical
- Start
- Dec 2025
- Modality
- Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of FibroCell-001 in lumbar intervertebral disc degenerative disease (LDDD), sponsored by Zhuiyuan Medical. Started Dec 2025; status: active.
02
Drugs
FibroCell-001
03
Conditions
lumbar intervertebral disc degenerative disease (LDDD)
Beyond the preview
Go deeper on CTR20254252.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20254252.